Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes - Douglas A. MacDonald; Joel Martin; Kathir K. Muthusamy; Jiann-Kae Luo; Erica Pyles; Ashique Rafique; Tammy Huang; Terra Potocky; Yang Liu; Jingtai Cao; Françoise Bono; Nathalie Delesque; et al. (Angiogenesis, 2016)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab - Nicholas Papadopoulos; Joel Martin; Qin Ruan; Ashique Rafique; Michael P. Rosconi; Ergang Shi; Erica A. Pyles; George D. Yancopoulos; Neil Stahl; Stanley J. Wiegand (Angiogenesis, 2012)